Atlas Trials

Shanghai BDgene Co., Ltd.

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Shanghai BDgene Co., Ltd.

RecordFirmDate
A Clinical Study on the Evaluation of BD114 for the Treatment HPV-16-Related Cervical HSIL (NCT07170254)Shanghai BDgene Co., Ltd.2025-09-01
A Phase Ⅱa Study of the Safety, Tolerability and Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis (NCT06474442)Shanghai BDgene Co., Ltd.2025-04-28
CRISPR/Cas9 Instantaneous Gene Editing Therapy to Intraocular Hypertensive POAG With MYOC Mutation (NCT06465537)Shanghai BDgene Co., Ltd.2024-06-10
A Phase 1 Study of Gene-modified Autologous Hematopoietic Stem Cell (BD211) Treating β-thalassemia Major (NCT06465550)Shanghai BDgene Co., Ltd.2024-01-05
Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent Beta-thalassemia (NCT05773729)Shanghai BDgene Co., Ltd.2023-09-15
A Study of the Safety, Tolerability and Prelinminary Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis (NCT06474416)Shanghai BDgene Co., Ltd.2023-09-04
Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent β-thalassemia (NCT05776173)Shanghai BDgene Co., Ltd.2023-08-10
A Study Evaluating the Safety and Efficacy of the BD211 Drug Product in β-Thalassemia Major Participants (NCT05015920)Shanghai BDgene Co., Ltd.2021-07-10

Track Shanghai BDgene Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.